Company Number: 14073492

Analysis Date: 2025-07-19 12:25 UTC

1. Market Position
   HAMIGA LIMITED operates as a private limited company primarily engaged in general medical practice activities, supplemented by real estate trading and leasing. Incorporated recently in 2022, the company currently occupies a niche at the intersection of healthcare services and real estate management, positioning itself within a specialized segment of the UK healthcare market that leverages property assets to support its operations.

2. Strategic Assets
   Key strengths include the sole ownership and control by a qualified medical professional, Dr. Gayathiri Sivavakeesar, which provides direct industry expertise and operational insight. The company’s dual focus on medical practice and real estate gives it a diversified asset base, reflected in its net assets increasing from £8,519 in 2023 to £17,081 in 2024, indicating growing equity. The modest but positive net current assets and shareholders’ funds demonstrate financial stability and operational prudence during its formative years. The director’s loan noted as debtors (£19,100) suggests internal financing flexibility, enhancing liquidity management.

3. Growth Opportunities
   HAMIGA LIMITED could capitalize on expanding its healthcare services footprint, possibly by integrating complementary medical specialties or telemedicine solutions to capture a broader patient base. The real estate component offers avenues for scaling through acquiring or developing additional properties tailored for healthcare delivery, thereby creating a synergistic asset-light model. Leveraging the director’s professional network could facilitate partnerships or contracts with NHS or private healthcare providers, driving revenue growth. Additionally, given the company’s current small scale, there is potential to professionalize operations and implement scalable systems to support expansion.

4. Strategic Risks
   The company’s reliance on a single director-owner exposes it to concentration risk, both in governance and operational continuity. The absence of employees indicates potential capacity constraints in service delivery and business development. The limited turnover and cash position (£1,092 in 2024) may restrict agility in responding to market opportunities or unexpected expenses. Furthermore, the niche combination of medical practice and real estate involves regulatory complexities in both sectors, which must be carefully managed to avoid compliance risks. Lastly, as a young entity, HAMIGA LIMITED faces typical startup challenges including brand recognition and competitive pressure from established healthcare providers.